Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
WeTRAIN is a new way to have fun with personal training. They are the first shared personal training company and by doing this, they are creating a market of social exercise. WeTRAIN makes it easy for friends to have high quality, personalised training in a variety of different classes.
days to go:
Expired
investment:
£437,138
The London Distillery Company (TLDC) is a producer of whiskies, gins and other amazing spirits. TLDC also produces a range of award-winning organic spirits under the 'Kew' and 'Dodd's' brands, with Kew being a unique collaboration with the Royal Botanic Gardens, Kew in London. TLDC exports to over 15 markets including China while export to Canada and 6 South East Asian markets are still in progress. Since November 2017, sales volumes have increased by 44% to £864k in Mar 2019. TLDC is looking to expand the sales team to drive growth both in the UK and abroad. Furthermore, TLDC has had significant media coverage with the ITV, BBC and The Financial Times. Additionally, the company have plans to launch in the USA and India by the end of 2019.
days to go:
Expired
investment:
£171,670
Solo Coffee is a company founded by Theo & Alex, aiming to simplify the world of specialty coffee. They've achieved £1.17 million in revenue for the financial year ending in April 2023 and break-even in March 2023 by producing espresso-strength cold brew coffee concentrate, which is used in various coffee applications, and they are now raising funds to support further growth in the rapidly growing Ready to Drink coffee market.
Solo Coffee's Coffee Concentrate has gained popularity, with over 7 million servings sold since its launch in October 2020. It is used in numerous bars in the UK and is one of the top 3 most sold chilled coffees on Amazon UK. The company is expanding its manufacturing to the US and targeting various channels, including foodservice, on-trade, retail, and direct-to-consumer, to make coffee preparation easier in different settings.
days to go:
Expired
investment:
£478,639
Integumen is a personal health company developing and commercialising technology and products for the human integumentary system that may improve physical appearance, hygiene and general health outcomes.
days to go:
Expired
investment:
£2,160,000
Intelligent Health aim to get the whole community active by providing games and incentives such as ''beat the street''. By providing schools and communities with friendly competition to walk and cycle more by tapping their cards on ''beat boxes'', and with prizes and league tables on offer, Intelligent health are bringing communities together.
days to go:
Expired
investment:
£700,000
PCL Health is a Business-to-Business (B2B) Software-as-a-Service (SaaS) entity that aims to bring hospital-level care to anyone remotely. It asserts that the correct use of remote monitoring can reduce mortality by up to 45%. PCL Health intends to become a contender in the remote healthcare market that is set to touch $30 billion by 2023. It has developed CE rated medical-grade devices that use health algorithms combined with sensors and its proprietary range of apps to allow family members to proactively monitor the health of their loved ones, alongside carers and doctors, remotely. PCL Health has completed two pilots with 65 people and received a Letter Of Intent (LOI) from a National Health Service (NHS) Trust for a clinical trial. It won the 'Innovative Startup' competition at the 2019 Healthcare Unblocked event. PCL Health will use the investment for technology enhancement, running further pilot studies, and working capital.
days to go:
Expired
investment:
£394,680
